Avoid Fraud, Get The Facts, And Find The Best
Legal Name: REDMILE GROUP, LLC
Period of report:
Jun 30, 2019
Effectiveness Date:
Aug 14, 2019
| Security |
Shares Held / Principal Amount |
Market Value |
Option |
|
Array Biopharma Inc (04269X105)
|
8,752,254 |
$405,492k |
|
|
AMICUS THERAPEUTICS INC (03152W109)
|
22,792,634 |
$284,452k |
|
|
Fate Therapeutics Inc (31189P102)
|
10,359,666 |
$210,301k |
|
|
Argenx SE Sponsored ADR (04016X101)
|
1,068,832 |
$151,325k |
|
|
UNIQURE N.V. (N90064101)
|
1,669,525 |
$130,473k |
|
|
AUDENTES THERAPEUTICS INC COM (05070R104)
|
2,972,167 |
$112,526k |
|
|
EPIZYME INC (29428V104)
|
8,729,142 |
$109,551k |
|
|
ALLAKOS INC COM (01671P100)
|
2,300,301 |
$99,672k |
|
|
ALDER BIOPHARMACEUTICALS INC (014339105)
|
8,244,896 |
$97,042k |
|
|
ATARA BIOTHERAPEUTICS INC (046513107)
|
4,600,917 |
$92,524k |
|
|
TRICIDA INC (89610F101)
|
1,945,200 |
$76,758k |
|
|
EHEALTH INC COM (28238P109)
|
888,705 |
$76,518k |
|
|
Bristol-Myers Squibb Co (110122108)
|
1,669,400 |
$75,707k |
|
|
TANDEM DIABETES CARE (875372203)
|
1,166,032 |
$75,232k |
|
|
REGENXBIO Inc. (75901B107)
|
1,391,376 |
$71,475k |
|
|
WAVE LIFE SCIENCES LTD (Y95308105)
|
2,719,707 |
$70,957k |
|
|
WRIGHT MEDICAL GROUP NV (NE) (N96617118)
|
2,372,157 |
$70,738k |
|
|
Xencor Inc. (98401F105)
|
1,612,798 |
$66,012k |
|
|
Sarepta Therapeutics Inc (803607100)
|
412,000 |
$62,603k |
|
|
ANTHEM INC (036752103)
|
183,500 |
$51,786k |
|
|
CELGENE CORP (151020104)
|
557,000 |
$51,489k |
|
|
CLOVIS ONCOLOGY INC COM (189464100)
|
3,462,300 |
$51,484k |
|
|
ARRAY BIOPHARMA INC (04269XAB1)
|
16,500,000 |
$50,155k |
|
|
DECIPHERA PHARMACEUTICALS IN (24344T101)
|
2,223,376 |
$50,137k |
|
|
SCHOLAR ROCK HLDG CORP (80706P103)
|
2,920,389 |
$46,317k |
|
|
KRYSTAL BIOTECH INC (501147102)
|
1,080,300 |
$43,504k |
|
|
CENTENE CORP DEL (15135B101)
|
690,870 |
$36,229k |
|
|
GRITSTONE ONCOLOGY INC (39868T105)
|
3,215,994 |
$35,826k |
|
|
UNITEDHEALTH GRP INC (91324P102)
|
141,901 |
$34,625k |
|
|
Anaptysbio Inc (032724106)
|
609,658 |
$34,397k |
|
|
XERIS PHARMACEUTICALS INC (98422L107)
|
3,000,641 |
$34,327k |
|
|
Syros Pharmaceuticals Inc (87184Q107)
|
3,620,376 |
$33,525k |
|
|
AXONICS MODULATION TECH INC (05465P101)
|
813,500 |
$33,329k |
|
|
REPLIMUNE GROUP INC (76029N106)
|
2,197,003 |
$32,208k |
|
|
Teladoc Health Inc (87918A105)
|
461,880 |
$30,673k |
|
|
LIVANOVA PLC (G5509L101)
|
423,987 |
$30,510k |
|
|
IMMUNOGEN INC (45253H101)
|
13,954,794 |
$30,282k |
|
|
STOKE THERAPEUTICS INC COM (86150R107)
|
1,021,808 |
$29,806k |
|
|
EIDOS THERAPEUTICS INC (28249H104)
|
878,403 |
$27,301k |
|
|
ODONATE THERAPEUTICS INC (676079106)
|
740,671 |
$27,175k |
|
|
DEXCOM INC (252131107)
|
172,100 |
$25,787k |
|
|
TCR2 THERAPEUTICS INC (87808K106)
|
1,799,216 |
$25,747k |
|
|
OXFORD IMMUNOTEC GLOBAL PLC (G6855A103)
|
1,796,477 |
$24,720k |
|
|
JAZZ PHARMA PLC (G50871105)
|
168,387 |
$24,005k |
|
|
GLYCOMIMETICS INC (38000Q102)
|
2,008,447 |
$23,941k |
|
|
ALDER BIOPHARMACEUTICALS INC (014339AA3)
|
25,000,000 |
$23,197k |
|
|
CymaBay Therapeutics, Inc. (23257D103)
|
3,138,365 |
$22,471k |
|
|
AKERO THERAPEUTICS INC (00973Y108)
|
1,168,802 |
$22,383k |
|
|
VAPOTHERM INC COM (922107107)
|
959,539 |
$22,069k |
|
|
Atreca, Inc. (04965G109)
|
1,140,306 |
$21,483k |
|
|
ADAPTIVE BIOTECHNOLOGIES COR (00650F109)
|
425,000 |
$20,528k |
|
|
MorphoSys AG (617760202)
|
733,699 |
$17,711k |
|
|
CHIMERIX INC (16934W106)
|
3,558,388 |
$15,372k |
|
|
HOOKIPA PHARMA INC (43906K100)
|
1,891,879 |
$12,732k |
|
|
PERSONALIS INC (71535D106)
|
400,000 |
$10,860k |
|
|
LOGICBIO THERAPEUTICS INC (54142F102)
|
814,898 |
$10,594k |
|
|
GLOBAL BLOOD THERAPEUTICS IN (37890U108)
|
188,000 |
$9,889k |
|
|
G1 THERAPEUTICS INC COM (3621LQ109)
|
292,734 |
$8,975k |
|
|
Invitae Corp (46185L103)
|
375,375 |
$8,821k |
|
|
BIOMARIN PHARMACEUTICAL INC (09061G101)
|
100,000 |
$8,565k |
Call |
|
PRINCIPIA BIOPHARMA INC (74257L108)
|
244,100 |
$8,102k |
|
|
GOSSAMER BIO INC (38341P102)
|
248,600 |
$5,514k |
|
|
BEIGENE LTD-ADR (07725L102)
|
39,900 |
$4,946k |
|
|
AVEDRO INC COM (05355N109)
|
216,200 |
$4,246k |
|
|
FORTY SEVEN INC (34983P104)
|
234,000 |
$2,480k |
|
|
OVID THERAPEUTICS INC (690469101)
|
737,550 |
$1,364k |
|
|
JOUNCE THERAPEUTIC (481116101)
|
254,590 |
$1,260k |
|
|
ENDOLOGIX INC (29266S304)
|
78,755 |
$570k |
|
|
VERICEL CORP (92346J108)
|
16,720 |
$316k |
|
|
MYOKARDIA INC (62857M105)
|
6,252 |
$313k |
|
|
AMEDISYS INC (023436108)
|
2,320 |
$282k |
|
|
HORIZON THERAPEUTICS PLC (G46188101)
|
11,400 |
$274k |
|
|
FLEXION THERAPEUTICS INC COM (33938J106)
|
21,630 |
$266k |
|
|
ADVERUM BIOTECHNOLOGIES INC (00773U108)
|
22,236 |
$264k |
|
|
LHC GROUP INC COM (50187A107)
|
2,166 |
$259k |
|
|
Neurocrine Biosciences Inc. (64125C109)
|
2,740 |
$231k |
|
|
Establishment Labs Holdings In (G31249108)
|
10,000 |
$220k |
|
|
NEVRO CORP COM (64157F103)
|
3,400 |
$220k |
|
|
VIKING THERAPEUTICS INC COM (92686J106)
|
16,260 |
$135k |
|
|
Castlight Health Inc (14862Q100)
|
10,229 |
$33k |
|
Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.
All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.
Recently Searched Firms
Please note: Search data is accumulated by 3rd party and refreshed once per day.